ASRT vs CVS · rev $125.0M vs P/E 16, rev $402.07B
Assertio Therapeutics Inc (ASRT) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ASRT currently screens at market cap $151.5M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ASRT and CVS stock pages for the full models.
Not investment advice.